0000000000429930

AUTHOR

Francesco Giovinazzo

showing 3 related works from this author

Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience.

2021

Background: Pseudomyxoma peritonei (PMP) originating from appendiceal mucinous neoplasm is a rare peritoneal malignancy characterized by the progressive intraperitoneal accumulation of mucus leading to death if left untreated. In recent years, cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) offered increased survival rates. This study aims to identify the clinical, pathological, and surgical features influencing safety and survival outcomes of patients undergoing CRS and HIPEC for PMP of appendiceal origin.Methods: A retrospective analysis of all patients undergoing CRS and HIPEC for PMP of appendiceal origin from January 2015 to May 2019 was cond…

medicine.medical_specialtyRD1-811HIPECbusiness.industrymedicine.diseaseSingle Centerhyperthermic intra peritoneal chemotherapyGastroenterologypseudomixoma peritoneiOxaliplatinRegimenperitonectomy procedureInternal medicinemedicinePeritoneal Cancer IndexAdenocarcinomaPseudomyxoma peritoneicytoreductive surgeryHyperthermic intraperitoneal chemotherapySurgerybusinessSurvival ratemedicine.drugOriginal ResearchFrontiers in surgery
researchProduct

Robotic-assisted pancreaticoduodenectomy with vascular resection. Description of the surgical technique and analysis of early outcomes

2019

Abstract Background Despite the potential benefits, the adoption of the minimally invasive surgery for the treatment of borderline resectable pancreatic cancer is still in the initial phase. We investigated the safety and feasibility of the robotic pancreaticoduodenectomy with venous resection/reconstruction (RPD SMV/PV). Methods Since March 2013 to October 2019, a total of 73 RPD and 10 RPD SMV/PV were performed. The two groups were case-matched according to the preoperative characteristics. Results Mean operative times and estimated blood loss were less in the RPD group in comparison to that in the RPD with SMV-PV group (525 vs 642 min, p = 0.003 and 290 vs 620 ml, p = 0.002, respectively…

Malemedicine.medical_specialtyRobotic assistedmedicine.medical_treatmentOperative TimeAdenocarcinoma030230 surgeryPancreaticoduodenectomy03 medical and health sciences0302 clinical medicineRobotic Surgical ProceduresBorderline resectablePancreatic cancerVascular reconstructionHumansMedicineRobotic surgeryVascular resectionAgedbusiness.industryMortality rateSurgical outcomesRobotic surgeryMiddle Agedmedicine.diseasePancreaticoduodenectomySurgeryPancreatic NeoplasmsTreatment OutcomeOncology030220 oncology & carcinogenesisInitial phaseFemaleSurgerybusinessVascular Surgical Procedures
researchProduct

Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis

2021

Introduction: Patients with peritoneal metastasis frequently develop malignant bowel obstruction (MBO). Medical palliative management is preferred but often fails. Conversely, the role of palliative surgery remains unclear and debated. This study aims to identify patients who could benefit from invasive surgical interventions and factors associated with successful surgical palliation.Materials and Methods: In this retrospective study, 98 consecutive patients who underwent palliative surgery for MBO over 5 years were reviewed. We evaluate as the primary outcome surgical failure to select patients who could benefit from palliative surgery, avoiding unnecessary surgery. A prognostic score was …

medicine.medical_specialtyRD1-811business.industrypalliative outcomesmalignant bowel obstruction (MBO)ileostomymedicine.diseaseSurgical failurePeritoneal carcinomatosisSurgeryBowel obstructionSettore MED/40 - GINECOLOGIA E OSTETRICIAperitoneal carcinomatosis (PC)MedicineSurgerybusinesssurgical palliationOriginal ResearchFrontiers in Surgery
researchProduct